Palvella Therapeutics
(NASDAQ) PVLA
Palvella Therapeutics Financials at a Glance
Market Cap
$2.10B
Revenue (TTM)
$0.00
Net Income (TTM)
-$49.30M
EPS (TTM)
-$4.17
P/E Ratio
-35.20
Dividend
$0.00
Beta (Volatility)
1.13 (Average)
Dividend
$0.00
Beta (Volatility)
1.13 (Average)
Price
$146.34
Volume
321,855.744
Open
$138.58
Price
$146.34
Volume
321,855.744
Open
$138.58
Previous Close
$146.76
Daily Range
$136.77 - $146.88
52-Week Range
$23.76 - $161.38
Estimated Earnings Date
Aug 13, 2026
Dividend
$0.00
Beta (Volatility)
1.13 (Average)
Price
$146.34
Volume
321,855.744
Open
$138.58
Previous Close
$146.76
Daily Range
$136.77 - $146.88
52-Week Range
$23.76 - $161.38
Estimated Earnings Date
Aug 13, 2026
PVLA News
PVLA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Palvella Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
29
CEO
Wesley H. Kaupinen, MBA
Website
www.palvellatx.comHeadquarters
Wayne, PA 19087, US
PVLA Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-56.87%
Return on Capital
-134.90%
Return on Assets
-18.69%
Earnings Yield
-2.84%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.10B
Shares Outstanding
14.34M
Volume
321.86K
Avg. Volume
263.14K
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$45.59M
EBITDA
-$36.56M
Operating Cash Flow
-$29.10M
Capital Expenditure
$0.00
Free Cash Flow
-$29.10M
Cash & ST Invst.
$261.85M
Total Debt
$584.00K
Palvella Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$2.10B
N/A
Market Cap/Employee
$150.35M
N/A
Employees
14
N/A
Net Income
-$15.77M
-92.6%
EBITDA
-$17.81M
-155.5%
Quarterly Fundamentals
Total Cash
$261.85M
+246.2%
Total Debt
$584.00K
N/A
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$375.00K
N/A
Short Term Debt
$209.00K
N/A
Return on Assets
-18.69%
N/A
Return on Invested Capital
-17.90%
N/A
Free Cash Flow
-$10.86M
-60.5%
Operating Cash Flow
-$10.86M
-60.5%